Midas Pharma

Midas Pharma is a German pharmaceutical company founded in 1988.

[1] The company has 300 employees (as of 2023) and revenue of 550 million EUR (2023).

Among other products,[2] it makes a biosimilar for ranibizumab under brand name Ranivisio, approved in 2022 by EMA.

This German corporation or company article is a stub.

You can help Wikipedia by expanding it.